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ImmunohistochemistryAbstract Mixed tumor of soft tissue is extremely rare; only 15 cases have been reported in English
literature. A 56-year-old man presented with a tumor in right arm. Physical examination showed a
tumor measuring 3 × 3 × 3 cm of deep portion of right arm. MRI showed a well-defined deep
tumor measuring 3 × 3 × 4 cm of arm next to fascia. The tumor was resected, and it was found
that the tumor is located in deep subcutaneous tissue outside the fascia. Histologically, the tumor
was well-defined and contained a fibrous capsule. The tumor cells showed no significant nuclear
atypia. The tumor was composed of epithelial, myoepithelial, and stromal elements. The epithelial
element formed tubules, and myoepithelial element showed solid nests and periepithelial linings.
The epithelial element showed frequent apocrine features including apocrine snouts. The stromal
element was composed of cartilage and myxoid tissues. Immunohistochemically, the epithelial
element was positive for cytokeratin (CK) AE1/3, CK CAM5.2, CK34BE12, CK7, CK8, CK18,
CK19, EMA, CEA, CD56, p53, and Ki-67 (labeling = 80%), but negative for CK5/6, CK14,
CK20, vimentin, p63, S100 protein, CD10, CD34, ASMA, CD68, myoglobin, bcl-2, BMP-2, TGF-
β1, CDK-4, and MDM2. The myoepithelial element was positive for CK AE1/3, CK CAM5.2,
CK34BE12, CK5/6, CK7, CK8, CK14, CK18, p63, vimentin, CD10, S100 protein, bcl-2, p53, and
Ki-67 (labeling = 20%), but negative for CK19, CK20, EMA, CEA, CD34, ASMA, CD68, CD56,
myoglobin, BMP-2, TGF-β1, CDK-4 and MDM2. The stromal element was positive for vimentin,
S100 protein (cartilage), and Ki-67 (labeling = 6%), but negative for other antigens examined
including bcl-2, BMP-2, TGF-β1, CDK-4 and MDM2. No findings of metastasis, invasion, and
recurrence were recognized clinically. The author speculates that the current mixed tumor was
derived from misplaced apocrine glands in the deep soft tissue.
© 2014 The Author. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction usually designated as pleomorphic adenoma or mixed tumorMixed tumor of the soft tissue is extremely rare; only 15
cases have been reported [1–4], to the best of author's
knowledge. Mixed tumor is most common in major and
minor salivary glands, and mixed tumor of these locations is⁎ Tel.: +81 54 336 1111; fax: +81 54 336 1315.
E-mail address: piyo0111jp@yahoo.co.jp.
ttp://dx.doi.org/10.1016/j.ehpc.2014.09.004
214-3300/© 2014 TheAuthor. Published by Elsevier Inc. Open access under CC B[5]. Mixed tumor is also seen in the skin, and such cutaneous
mixed tumor is usually called chondroid syringoma [6].
Mixed tumor is extremely rare in the soft tissue [1–4,7].
According to WHO blue book [7], mixed tumor of soft
tissue is included in a group of mixed tumor/myoepithe-
lioma/parachordoma. Mixed tumor is composed of epithe-
lial, myoepithelial, and mesenchymal cells which often
show cartilage, and shows pleomorphic diverse features ofY-NC-ND license.
53Mixed tumor of soft tissuehistology [1–7]. According to WHO blue book [7], in the
section of mixed tumor/myoepithelioma/parachordoma
group of soft tissue, mixed tumor is used for tumor having
epithelial tubular element, and myoepithelioma for tumor
lacking epithelial tubular element [7]. Parachordoma is a
vague entity, and should be included in mixed tumor or
myoepithelioma [7]. Thus, mixed tumor and myoepithe-
lioma are different histological entities [7], although the
histology is mutually similar. There has been only one study
of soft tissue mixed tumor with immunohistochemical
study, which was performed by Kilpatrick et al. [1]. Herein
reported is a case of mixed tumor of the soft tissue of arm.
An extensive immunohistochemical study was performed in
this case report.2. Case report
A 56-year-old man noticed a tumor in right arm, and
consulted to our hospital. Physical examination showed a
deep tumor measuring 3 × 3 × 3 cm in the right arm. No
other skin tumor was found. MRI showed a well-defined
deep tumor measuring 3 × 3 × 4 cm of the arm next to
fascia (Fig. 1). The resonance density of the tumor is
heterogenous (Fig. 1). The tumor was excised. During the
operation, it was found that the tumor was located in deep
subcutaneous tissue next to fascia. It was not within the
striated muscles. No tumor was found in the overlying skin
and upper subcutaneous tissue.Fig. 1 MRI findings of the right arm tumor. MRI showed a
well-defined deep tumor measuring 3 × 3 × 4 cm of the arm
next to fascia. The density of the tumor is heterogenous.Histologically, the tumor was well-defined and con-
tained a fibrous capsule (Fig. 2A). The resected section
included the epidermis and dermis, and the distance
between superficial part of the tumor and superficial
epidermis was 12 mm. The tumor cells showed no
significant nuclear atypia. The tumor showed pleomorphic
diverse histologies, but basically the tumor was composed
of epithelial, myoepithelial, and stromal elements (Fig. 2A
and B). The epithelial element formed tubules (Fig. 2C),
and myoepithelial element showed solid nests (Fig. 2D)
and periepithelial linings (Fig. 2C). The epithelial element
showed frequent apocrine features including apocrine
snouts and ample acidophilic cytoplasm (Fig. 2E). Some
areas of the myoepithelial element were composed of
myoepithelial cells with clear cytoplasm. The stromal
element was composed of cartilage (Fig. 2F) and myxoid
tissue. There were gradual transitions between the
myoepithelial element and stromal element. No apparent
carcinoma areas were seen.
An immunohistochemical analysis was performed by
the Envision method (Dako Corp, Glostrup, Denmark), as
previously reported [8–13]. The results are shown in
Table 1. Immunohistochemically, the epithelial element
was positive for cytokeratin (CK) AE1/3, CK CAM5.2
(Fig. 3A), CK34BE12, CK7 (Fig. 3B), CK8, CK18
(Fig. 3C), CK19, epithelial membrane antigen (EMA)
(Fig. 3D), carcinoembryonic antigen (CEA) (Fig. 3E),
CD56 (Fig. 3F), p53, and Ki-67 (labeling = 80%)
(Fig. 4A), but negative for CK5/6 (Fig. 4B), CK14
(Fig. 4C), CK20, vimentin (Fig. 4D), p63 (Fig. 4E), S100
protein (Fig. 4F), CD10, CD34, α-smooth muscle antigen
(ASMA), CD68, myoglobin, bcl-2, bone morphogenic
protein-2 (BMP-2), transforming growth factor-β1
(TGF-β1), cyclin dependent kinase (CDK-4), and
MDM2. The myoepithelial element was positive for CK
AE1/3, CK CAM5.2 (Fig. 3A), CK34BE12, CK5/6
(Fig. 4B), CK7 (Fig. 3B), CK8, CK14 (Fig. 4C), CK18
(Fig. 3C), p63 (Fig. 4E), vimentin (Fig. 4D), S100 protein
(Fig. 4F), CD10, bcl-2, p53, and Ki-67 (labeling = 20%),
but negative for CK19, CK20, EMA (Fig. 3D), CEA
(Fig. 3E), CD34,ASMA,CD68,CD56,myoglobin, BMP-2,
TGF-β1, CDK-4 and MDM2. The stromal element was
positive for vimentin, S100 protein (cartilage), and Ki-67
(labeling = 6%), but negative for any types of CK, EMA,
p63, CD10, CD34, CD68, p53, ASMA, CD56, myoglo-
bin, bcl-2, BMP-2, TGF-β1, CDK-4 and MDM2. The
stromal element was positive for vimentin, S100 protein
(cartilage), and Ki-67 (labeling = 6%), but negative for
any types of CK, EMA, p63, CD10, CD34, CD68, p53,
ASMA, CD56, myoglobin, bcl-2, BMP-2, TGF-β1,
CDK-4 and MDM2.
No findings of metastasis, invasion or recurrence were
noted clinically. Clinical examination identified no tumors in
head and neck regions including the salivary glands and oral
Fig. 2 Histopathologic findings of the soft tissue tumor of the arm. A: Low power view. The tumor is round and well-defined. The
tumor has complete capsule. The tumor is composed of cartilage, myoepithelial solid nests, and epithelial tubules. HE: ×20. B:
Intermediate power view. The soft tissue tumor is composed of epithelial element forming tubules (lower), myoepithelial element forming
solid nests (left) and peritubular linings (lower), and stromal element including myxoid tissue (center) and cartilage (upper). HE: ×40. C:
High power view of the tubular epithelial element and peritubular myoepithelial element. The epithelial cells form tubules, and
myoepithelial cells are present outside the peritubular epithelial cells. HE: ×200. D: Intermediate power view. The myoepithelial cells
form solid cell nests. HE: ×200. E: Very high power view. The tubular epithelial cells show apocrine features of apocrine snouts and
acidophilic ample cytoplasm. HE: ×400. F: High power view. The stromal element shows cartilage. HE: ×200.
54 T. Teradacavity. No skin tumor was found. The patient is now healthy
and free from tumors or diseases 43 months after the
operation.3. Discussion
Mixed tumor of the soft tissue is extremely rare. The
current case is the 21st case of mixed tumor of soft tissue
after Kilpatrick et al. (18 cases) [1], Pauwels et al. (one
case) [2], Adachi et al. (one case) [3], and Tomoeda et al.(one case) [4] in the English literature, to the best of the
author's knowledge. The current tumor was located in the
deep subcutaneous tissue just adjacent to fascia. The tumor
was not located in the striated muscles, and no skin tumor
was found. Therefore, the present tumor is not a cutaneous
tumor or a muscular tumor but a soft tissue tumor. Thus,
the present tumor is not chondroid syringoma of the skin.
Further, the current tumor is located in the area containing
no salivary glands. Therefore, the present tumor is not
pleomorphic adenoma or mixed tumor of salivary glands.
According to WHO blue book [5–7], mixed tumor
(pleomorphic adenoma or chondroid syringoma) is
Table 1 Immunohistochemical findings of the present
tumor.
Antigens Epithelial
element
Myoepithelial
element
Stromal
element
CK AE1/3 +++ ++ −
CK CAM5.2 ++ + −
CK34BE12 + +++ −
CK5/6 − +++ −
CK7 ++ + −
CK8 ++ + −
CK14 − + −
CK18 + + −
CK19 + − −
CK20 − − −
Vimentin − +++ ++
EMA ++ − −
CEA + − −
S100 protein − ++ + (cartilage)
CD10 − +++ −
CD56 + − −
p53 + + −
p63 − +++ −
Ki-67 LI 80% 20% 6%
CD34 − − −
ASMA − − −
CD68 − − −
Myoglobin − − −
Bcl-2 − ++ −
BMP-2 − − −
TGFβ1 − − −
CDK-4 − − −
MDM2 − − −
CK: cytokeratin. EMA: epithelialmembrane antigen. LI: labeling index,
ASMA: alpha-smooth muscle antigen. CEA: carcinoembryonic antigen.
BMP-2: bone morphogenic protein-2. TGF-beta1 transforming growth
factor-β1. CDK4: cyclin dependent kinase.
MDM2. The myoepithelial element was positive for CK AE1/3, CK
CAM5.2 (Fig. 3A), CK34BE12, CK5/6 (Fig. 4B), CK7 (Fig. 3B), CK8,
CK14 (Fig. 4C), CK18 (Fig. 3C), p63 (Fig. 4E), vimentin (Fig. 4D),
S100 protein (Fig. 4F), CD10, bcl-2, p53, and Ki-67 (labeling = 20%),
but negative for CK19, CK20, EMA (Fig. 3D), CEA (Fig. 3E), CD34,
ASMA, CD68, CD56, myoglobin, BMP-2, TGF-β1, CDK-4 and
MDM2. The stromal element was positive for vimentin, S100 protein
(cartilage), andKi-67 (labeling = 6%), but negative for any types of CK,
EMA, p63, CD10, CD34, CD68, p53, ASMA, CD56, myoglobin, bcl-2,
BMP-2, TGF-β1, CDK-4 and MDM2.
55Mixed tumor of soft tissuedefined as a tumor of variable capsulation characterized
microscopically by architectural rather than cellular
pleomorphism. Epithelial and modified myoepithelial
elements intermingle most commonly with tissues of
mucoid, myxoid and chondroid appearance [5–7]. The
current tumor was completely encapsulated. The present
tumor was composed of epithelial, myoepithelial, and
stromal elements, and showed diverse and pleomorphic
cellular architecture. The epithelial and myoepithelial cellswere verified by immunohistochemistry of epithelial
markers such as various CK profile, EMA and CEA and
by immunohistochemistry of myoepithelial markers such
as CK34BE12, CK5/6, CK14, p63, S100 protein, and
CD10. The stromal element of the current tumor contained
myxoid tissue and cartilage. Therefore, the current soft
tissue tumor is authentic mixed tumor because the current
tumor fulfills the criteria of mixed tumor of WHO books
[5–7]. The present tumor is not myoepithelioma of soft
tissue, because the epithelial cells were present and they
formed glandular structures [7]. The current mixed tumor
of the soft tissue is not metastatic tumor, because careful
examination of the major salivary glands, oral cavity, and
skin identified no tumors. The current tumor is not
malignant. No apparent carcinoma was seen, indicating the
present tumor is not carcinoma ex pleomorphic adenoma
(mixed tumor). The current tumor appears not to be
malignant pleomorphic adenoma or mixed tumor (metas-
tasizing pleomorphic adenoma), which shows benign
histologic features. However, malignant mixed tumor
cannot be excluded completely. The tumor-free follow-up
period of 43 months in the present patient suggests the
benign nature of the tumor.
The origin of mixed tumor of the soft tissue is an
enigma, and no consideration has been done [1–4,7]. The
rarity of cases of soft tissue mixed tumor may hinder the
consideration of original cells. It is very curious that mixed
tumor can arise in soft tissue devoid of epithelial cells. In
the current case, apocrine features with apocrine snouts
were seen in the epithelial tumor cells. The author
speculates that the current mixed tumor was derived
from misplaced apocrine glands in the deep soft tissue of
the arm. Otherwise, pulripotential stem cells of the soft
tissue might give rise to the mixed tumor of the soft tissue.
The present study employed extensive immunohisto-
chemical study. The immunoprofile of mixed tumor of the
salivary glands has been studied. The epithelial cells of
mixed tumor of salivary glands are positive for CK3, CK6,
CK10, CK11, CK13 and CK16, while the neoplastic
myoepithelial cells express CK13, CK14 and CK16. These
findings are somewhat different from those of the current
case. It has been known that the neoplastic myoepithelial
cells co-express vimentin and pan-CK and are variably
positive for S100 protein, ASMA, GFAP, calponin, CD10,
p63 and muscle-specific actin (HHF-35). These findings of
neoplastic myoepithelial cells in mixed tumor of salivary
glands are compatible with the findings of the current case.
The neoplastic myoepithelial cells near the stromal element
of mixed tumor express BMP [5]. However, the current
mixed tumor of the soft tissue did not express BMP.
Immunohistochemical study of mixed tumor of the soft
tissue has been performed only once by Kilpatrick et al.
[1]. They demonstrated that mixed tumor (18 cases) and
myoepithelioma (one case) of the soft tissue expressed
Fig. 3 Immunohistochemical findings. Cytokeratin (CK) CAM5.2 (A), CK7 (B), and CK18 (C) are expressed in both epithelial cells
and myoepithelial cells. EMA (D), CEA (E), and CD56 (F) are expressed in epithelial cells but not in myoepithelial cells. ×200.
56 T. Teradapan-CK in 16/16, S100 protein in 16/17, ASMA in 6/14,
muscle specific actin (HHF-35) in 2/10, desmin in 2/10,
GFAP in 3/11, and EMA in 3/16. Immunohistochemical
result of the present case (Table 1) is basically similar to
the data of Kilpatrick et al. [1]. The present case of mixed
tumor of the soft tissue revealed the CK immunoprofile in
the epithelial and myoepithelial cells. Of interest is that
CD5/6, CK34BE12, and CK14 were expressed in the
myoepithelial cells but not in the epithelial cells. These
types of CK are known to be expressed in myoepithelial
cells. CD10 expression showed a similar pattern; CD10 is
well known to be expressed in myoepithelial cells [1,10].Fig. 4 Immunohistochemical expressions. Ki-67 labeling is high in epit
CK20, vimentin (D), p63 (E) and S100 protein (F) are expressed in myoeVimentin, S100 protein and p63 labeled myoepithelial
cells but not epithelial cells, being compatible with other
study [1,5–7,10]. EMA and CEA were expressed in
epithelial cells but not in myoepithelial cells. These are
new findings. Expression of bcl-2 was seen in myoepithelial
cells but not in epithelial cells, suggesting that bcl-2may be a
marker of myoepithelial cells. This is a novel finding. CD56
(NCAM) expression was seen in epithelial cells but not in
myoepithelial cells, suggesting that epithelial cells of mixed
tumor of the soft tissue show neuroendocrine features. In the
present case, no ASMA expression is seen in both epithelial
cells and myoepithelial cells, although ASMA is a goodhelial cells (labeling = 80%) (A). In contrast, CK5/6 (B), CK14 (C),
pithelial cells, but not in epithelial cells. ×200.
57Mixed tumor of soft tissuemarker of myoepithelial cells [5–7,10]. Expression of p53
was present in both epithelial and myoepithelial cells,
suggesting that the both cell types in mixed tumor of the soft
tissue have p53 gene mutations. In the current case, the Ki-67
labeling is very high (80%) in epithelial cells and
relatively high (20%) in the myoepithelial cells, suggesting
that both cell types have high cell proliferative activity.
However, positive p53 and high Ki-67 labeling of the
present case do not imply that the present tumor is
malignant, because HE histology did not show malignant
features. No expression of BMP-2, TGF-β1, CDK-4 and
MDM2 was noted in all the three elements of the mixed
tumor of the current case. BMP-2 and TGF-β1 play an
important role in the formation of bone and cartilage. It is
thought that the stromal element including myxoid tissue,
cartilage and bone of mixed tumor is derived from
myoepithelial cells [5–7]. The negative BMP-2 and
TGF-β1 reactivities in the present mixed tumor suggest
that BMP-2 and TGF-β1 are not essential in the
differentiation of myoepithelial cells into bone and cartilage
in mixed tumor. The negative CDK-4 and MDM2 in the
current mixed tumor suggest that these oncoproteins and
oncogenes do not function in the pathogenesis of mixed
tumor. Myoglobin was negative in all the three elements,
implying no participation of this protein in the pathogenesis
of mixed tumor. In the stromal element of mixed tumor, only
vimentin, S100, and Ki-67 were positive, and other antigens
examined were negative, suggesting that these other
antigens do not play a part in the differentiation of
myoepithelial cells into the stromal element in mixed
tumor of soft tissue.
In summary, the author reported an extremely rare case of
mixed tumor of the soft tissue. An extensive immunohisto-
chemical study was performed in the mixed tumor of the
soft tissue.
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